Dergiler / Turkish Journal of Pediatrics / 2021 / Cilt: 63 - Sayı: 6

Microbiological characteristics and outcomes of children with pleural empyema admitted to a tertiary hospital in southeast China, 2009-2018

Sayfa
994–1003
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The prognosis is good after appropriate therapy

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Pleural empyema is one of the most serious and life-threatening types of infection in children.
📊
Temel Bulgular & Veri:A retrospective review was conducted of the medical records of 63 children admitted to a tertiary hospital in China with pleural empyema between January 2009 and December 2018.
💡
Sonuç & Katkı:The prognosis is good after appropriate therapy
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:2009 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

Background. Pleural empyema is one of the most serious and life-threatening types of infection in children. The aim of this study was to describe the microbiological characteristics and outcomes of children with pleural empyema. Methods. A retrospective review was conducted of the medical records of 63 children admitted to a tertiary hospital in China with pleural empyema between January 2009 and December 2018. Results. The children had a median age of 1 year (range: 2 months to 16 years) and 33 (52.4%) were female. Bacterial isolates included Staphylococcus aureus (n=15, 23.8%), Streptococcus pneumoniae (n=10, 15.9%), Pseudomonas aeruginosa (n=7, 11.1%), Escherichia coli (n=2, 3.2%), Burkholderia cepacia (n=2, 3.2%), Enterobacter cloacae (n=1, 1.6%), Klebsiella pneumoniae (n=1, 1.6%), and Streptococcus constellation (n=1, 1.6%). All 15 Staphylococcus aureus isolates were found to be resistant to penicillin, and the rate of methicillin-resistant Staphylococcus aureus was high (66.7%,10/15). Overall, 5 of 10 Streptococcus pneumoniae isolates were susceptible to penicillin. Each Staphylococcus aureus and Streptococcus pneumoniae isolate showed susceptibility to vancomycin. Ceftazidime was effective against all Pseudomonas aeruginosa isolates. Of the 63 children, 60 improved, no one died. Conclusions. Staphylococcus aureus and Streptococcus pneumoniae were the leading cause of pleural empyema. Antimicrobial susceptibility testing revealed a high percentage of resistance against penicillin while vancomycin provided 100% coverage for these pathogens. Pseudomonas aeruginosa is the third most common pathogen mainly detected in those under 3 years old in the summer and have shown to be susceptible to ceftazidime. The prognosis is good after appropriate therapy

🔖

Bu Makaleye Atıf Yap

ZHANG, X., ZHANG, H. (2021). Microbiological characteristics and outcomes of children with pleural empyema admitted to a tertiary hospital in southeast China, 2009-2018. Turkish Journal of Pediatrics, Cilt: 63 - Sayı: 6, 994–1003. https://ajindex.com/articles/411775

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (1)

  1. Mandal KC, Mandal G, Halder P, Mitra D, Debnath B, Bhattacharya M. Empyema thoracis in children: a 5-year experience in a tertiary care institute. J Indian Assoc Pediatr Surg 2019; 24: 197-202. https://doi. org/10.4103/jiaps.JIAPS_112_18 2. Corcoran JP, Wrightson JM, Belcher E, DeCamp MM, Feller-Kopman D, Rahman NM. Pleural infection: past, present, and future directions. Lancet Respir Med 2015; 3: 563-577. https://doi.org/10.1016/S2213- 2600(15)00185-X 3. Dyrhovden R, Nygaard RM, Patel R, Ulvestad E, Kommedal Ø. The bacterial aetiology of pleural empyema. A descriptive and comparative metagenomic study. Clin Microbiol Infect 2019; 25: 981-986. https://doi.org/10.1016/j.cmi.2018.11.030 4. Grijalva CG, Zhu Y, Nuorti JP, Griffin MR. Emergence of parapneumonic empyema in the USA. Thorax 2011; 66: 663-668. https://doi.org/10.1136/ thx.2010.156406 5. Liese JG, Schoen C, van der Linden M, et al. Changes in the incidence and bacterial aetiology of paediatric parapneumonic pleural effusions/empyema in Germany, 2010-2017: a nationwide surveillance study. Clin Microbiol Infect 2019; 25: 857-864. https:// doi.org/10.1016/j.cmi.2018.10.020 6. Bedawi EO, Hassan M, McCracken D, Rahman NM. Pleural infection: a closer look at the etiopathogenesis, microbiology and role of antibiotics. Expert Rev Respir Med 2019; 13: 337-347. https://doi.org/10.1080 /17476348.2019.1578212 7. Balfour-Lynn IM, Abrahamson E, Cohen G, et al; Paediatric Pleural Diseases Subcommittee of the BTS Standards of Care Committee. BTS guidelines for the management of pleural infection in children. Thorax 2005; 60(Suppl 1): i1-i21. https://doi.org/10.1136/ thx.2004.030676 8. Shen KR, Bribriesco A, Crabtree T, et al. The American Association for Thoracic Surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg 2017; 153: e129-e146. https://doi.org/10.1016/j.jtcvs.2017.01.030 9. Byington CL, Spencer LY, Johnson TA, et al. An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations. Clin Infect Dis 2002; 34: 434-440. https://doi.org/10.1086/338460 10. Lamas-Pinheiro R, Henriques-Coelho T, Fernandes S, et al. Thoracoscopy in the management of pediatric empyemas. Rev Port Pneumol (2006) 2016; 22:157- 162. https://doi.org/10.1016/j.rppnen.2015.12.004 11. Eastham KM, Freeman R, Kearns AM, et al. Clinical features, aetiology and outcome of empyema in children in the north-east of England. Thorax 2004; 5